Qian W - Search Results

1

Patient reported outcome measures (PROMs) following forward planned field-in field IMRT: results from the Cambridge Breast IMRT trial.

Mukesh MB, Qian W, Wilkinson JS, Dorling L, Barnett GC, Moody AM, Wilson C, Twyman N, Burnet NG, Wishart GC, Coles CE. Mukesh MB, et al. Among authors: qian w. Radiother Oncol. 2014 May;111(2):270-5. doi: 10.1016/j.radonc.2014.02.016. Epub 2014 Apr 16. Radiother Oncol. 2014. PMID: 24746570 Clinical Trial.

2

Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis.

Mukesh MB, Barnett GC, Wilkinson JS, Moody AM, Wilson C, Dorling L, Chan Wah Hak C, Qian W, Twyman N, Burnet NG, Wishart GC, Coles CE. Mukesh MB, et al. Among authors: qian w. J Clin Oncol. 2013 Dec 20;31(36):4488-95. doi: 10.1200/JCO.2013.49.7842. Epub 2013 Sep 16. J Clin Oncol. 2013. PMID: 24043742 Clinical Trial.

3

Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial.

Lowry L, Smith P, Qian W, Falk S, Benstead K, Illidge T, Linch D, Robinson M, Jack A, Hoskin P. Lowry L, et al. Among authors: qian w. Radiother Oncol. 2011 Jul;100(1):86-92. doi: 10.1016/j.radonc.2011.05.013. Epub 2011 Jun 12. Radiother Oncol. 2011. PMID: 21664710 Clinical Trial.

4

Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial.

Ardeshna KM, Qian W, Smith P, Braganca N, Lowry L, Patrick P, Warden J, Stevens L, Pocock CF, Miall F, Cunningham D, Davies J, Jack A, Stephens R, Walewski J, Ferhanoglu B, Bradstock K, Linch DC. Ardeshna KM, et al. Among authors: qian w. Lancet Oncol. 2014 Apr;15(4):424-35. doi: 10.1016/S1470-2045(14)70027-0. Epub 2014 Mar 4. Lancet Oncol. 2014. PMID: 24602760 Clinical Trial.

5

A Comparison of Outcomes Following Laparoscopic and Open Hysterectomy With or Without Lymphadenectomy for Presumed Early-Stage Endometrial Cancer: Results From the Medical Research Council ASTEC Trial.

Kyrgiou M, Swart AM, Qian W, Warwick J. Kyrgiou M, et al. Among authors: qian w. Int J Gynecol Cancer. 2015 Oct;25(8):1424-36. doi: 10.1097/IGC.0000000000000521. Int J Gynecol Cancer. 2015. PMID: 26244758 Clinical Trial.

6

Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours.

Meyer T, Qian W, Caplin ME, Armstrong G, Lao-Sirieix SH, Hardy R, Valle JW, Talbot DC, Cunningham D, Reed N, Shaw A, Navalkissoor S, Luong TV, Corrie PG. Meyer T, et al. Among authors: qian w. Eur J Cancer. 2014 Mar;50(5):902-11. doi: 10.1016/j.ejca.2013.12.011. Epub 2014 Jan 17. Eur J Cancer. 2014. PMID: 24445147 Clinical Trial.

7

Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial.

Thatcher N, Qian W, Clark PI, Hopwood P, Sambrook RJ, Owens R, Stephens RJ, Girling DJ. Thatcher N, et al. Among authors: qian w. J Clin Oncol. 2005 Nov 20;23(33):8371-9. doi: 10.1200/JCO.2004.00.9969. J Clin Oncol. 2005. PMID: 16293867 Clinical Trial.

8

Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial.

Crosbie EJ, Roberts C, Qian W, Swart AM, Kitchener HC, Renehan AG. Crosbie EJ, et al. Among authors: qian w. Eur J Cancer. 2012 Apr;48(6):853-64. doi: 10.1016/j.ejca.2011.10.003. Epub 2011 Nov 17. Eur J Cancer. 2012. PMID: 22100903 Clinical Trial.

9

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.

Rustin GJ, van der Burg ME, Griffin CL, Guthrie D, Lamont A, Jayson GC, Kristensen G, Mediola C, Coens C, Qian W, Parmar MK, Swart AM; MRC OV05; EORTC 55955 investigators. Rustin GJ, et al. Among authors: qian w. Lancet. 2010 Oct 2;376(9747):1155-63. doi: 10.1016/S0140-6736(10)61268-8. Lancet. 2010. PMID: 20888993 Free article. Clinical Trial.

10

Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trial.

Stark DP, Cook A, Brown JM, Brundage MD, Embleton AC, Kaplan RS, Raja FA, Swart AMW, Velikova G, Qian W, Ledermann JA. Stark DP, et al. Among authors: qian w. Cancer. 2017 Jul 15;123(14):2752-2761. doi: 10.1002/cncr.30657. Epub 2017 Mar 24. Cancer. 2017. PMID: 28339098 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,221 results

Search Page

Filters